A landmark multicenter randomized controlled clinical trial published in The Lancet Infectious Diseases and presented at ESCMID Global 2026 demonstrates that implementing a standardized daily oral hygiene protocol across acute hospital wards reduces the risk of non-ventilator-associated hospital-acquired pneumonia (NV-HAP) by 60 percent. Known as the Hospital Acquired Pneumonia Prevention (HAPPEN) trial, the collaborative study conducted by researchers from Avondale University and Queensland University of Technology represents the largest and most rigorous randomized controlled trial to date evaluating bedside oral decontamination for preventing pneumonia in hospitalized patients. Stepped-Wedge Cluster Trial Enrolls Nearly Nine Thousand Inpatients Hospital-acquired pneumonia is one of the most prevalent and lethal healthcare-associated infections encountered in clinical practice. In Australia alone, approximately 50,000 patients contract hospital-acquired pneumonia annually, resulting in roughly 1,900 deaths; hospitalized patients who develop pneumonia are eight times more likely to die during their stay than those who do not. Although non-ventilator-associated cases account for the vast majority of hospital pneumonia cases—far exceeding cases of ventilator-associated pneumonia (VAP) in intensive care units (ICUs)—the implementation of routine bedside oral hygiene across general medical and surgical wards has historically lacked definitive evidence from high-quality clinical trials.
Stepped-Wedge Trial Tests Oral Care on 8,870 Patients
To evaluate whether structured oral care could curb pneumonia rates, investigators launched a 12-month, open-cohort, stepped-wedge cluster randomized controlled trial across nine inpatient wards within three large Australian hospitals. The trial enrolled 8,870 adult patients admitted for 48 hours or longer between June 2024 and August 2025. Employing a stepped-wedge methodology to mitigate contamination, participating wards sequentially transitioned from standard care to the oral care intervention at three-month intervals until all units integrated the protocol.
The clinical intervention was intentionally designed to be practical, scalable, and readily integrated into routine bedside workflows. Upon hospital admission, patients received an oral hygiene kit containing a soft toothbrush, fluoride toothpaste, and educational brochures outlining how daily tooth cleaning protects pulmonary health. The toothbrush itself featured a prominent printed reminder reading "Brush away pneumonia." Inpatient nursing staff participated in practical training sessions supported by real-time digital guidelines. For patients experiencing cognitive impairment, frailty, or functional immobility, nursing staff provided hands-on assistance, reinforced by regular clinical audits and ward feedback. Pneumonia Risk Plummets Sixty Percent as Oral Care Adherence Surges Among the 8,870 patients evaluated in the primary analysis, 4,523 patients received usual care in the control cohort and 4,347 patients were managed under the oral care intervention. Prospective surveillance confirmed 78 total cases of non-ventilator-associated hospital-acquired pneumonia (an overall incidence of 0.9 percent). Specifically, 46 cases developed among the 4,523 control patients (1.0 percent), whereas only 32 cases occurred among the 4,347 intervention patients (0.7 percent).
After adjusting for observation time and patient-level confounding factors in proportional hazards modeling, exposure to the intervention produced a dramatic protective effect. Researchers documented a cumulative hazard ratio of 0.40 (95% confidence interval 0.19 to 0.82), representing an approximate 60 percent reduction in pneumonia risk. Expressed per person-time at risk, pneumonia incidence plunged from 1.00 infections per 100 admission-days in the control condition to 0.41 infections per 100 admission-days during the intervention period. Ward audits revealed that bedside oral care was delivered an average of 1.5 times daily, while the proportion of patients completing routine oral hygiene jumped from 15.9 percent in the control phase to 61.9 percent following intervention rollout.
Brett Mitchell Links Micro-Aspiration to Infection Control Guidelines
Chief investigator Brett Mitchell, PhD, Professor of Nursing and Health Services Research at Avondale University, emphasized the clinical impact: "We've shown that through a simple intervention, you can help reduce one of the most common infections in hospital, one that's associated with significant morbidity, mortality, and increased length of stay." Co-investigator Dr. Nicole White from Queensland University of Technology highlighted that the demonstrated 60 percent reduction provides vital, actionable evidence to update infection prevention guidelines both in Australia and internationally. Halting Micro-Aspiration to Transform Inpatient Infection Control Guidelines The clinical findings reinforce the established biological mechanism underlying hospital-acquired pneumonia. During hospitalization, acute illness, immobilization, and pharmacological therapies rapidly disrupt the oral microbiome, allowing pathogenic gram-negative bacilli and staphylococci to proliferate across dental plaque, mucosal surfaces, and the tongue. When patients micro-aspirate colonized secretions into the lower respiratory tract—especially during sleep or due to mild dysphagia—pulmonary infection readily develops.
Professor Mitchell explained that NV-HAP typically occurs when fluids from the oral cavity enter the lungs, with hospital-associated pathogens frequently isolated from patients unable to clear oral secretions effectively. Because these infections arise primarily from endogenous microbial colonization rather than cross-transmission between patients, diligent mechanical oral hygiene significantly reduces oral bacterial bioburden and interrupts the pathway to pulmonary inoculation. These findings align with a prior systematic review and meta-analysis of 15 clinical trials comprising 10,742 patients published in JAMA Internal Medicine, which demonstrated that daily toothbrushing significantly reduced pneumonia rates and ICU mortality. By providing definitive clinical proof, the HAPPEN study establishes that basic oral hygiene must transition from an informal comfort measure into a mandatory core strategy for hospital infection control.
